<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">  <id>24514ba3-2f49-4c01-809e-e6d812ddb245</id>  <name>Ketone Testing for patients on Insulin or SGLT2 Inhibitors Order Group</name>  <description>    <lifecycle_state>Initial</lifecycle_state>    <details>      <purpose />      <use />      <misuse />    </details>    <other_details>      <item>        <key>MetaDataSet:Sample Set </key>        <value>Template metadata sample set </value>      </item>      <item>        <key>Acknowledgements</key>        <value />      </item>      <item>        <key>Business Process Level</key>        <value />      </item>      <item>        <key>Care setting</key>        <value />      </item>      <item>        <key>Client group</key>        <value />      </item>      <item>        <key>Clinical Record Element</key>        <value />      </item>      <item>        <key>Copyright</key>        <value />      </item>      <item>        <key>Issues</key>        <value />      </item>      <item>        <key>Owner</key>        <value />      </item>      <item>        <key>Sign off</key>        <value />      </item>      <item>        <key>Speciality</key>        <value />      </item>      <item>        <key>User roles</key>        <value />      </item>    </other_details>  </description>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">    <items>      <item>        <key>CKT.Clinical Guidance</key>        <value>&lt;p&gt;Serum ketones (beta-hydroxybutyrate) is preferred over urine ketones for diagnosis of DKA where this test available.&lt;/p&gt;</value>      </item>      <item>        <key>Technical.ï»© Technical Traceability</key>        <value>{~AHSID~24514ba3-2f49-4c01-809e-e6d812ddb245~NAME~Ketone Testing for patients on Insulin or SGLT2 Inhibitors Order Group}</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value='Beta-Hydroxybutyrate (BOH); Blood, Venous; Conditional PRN']/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;To be released if blood glucose of greater than 18 mmol/L or greater than 14 mmol/L on self-management of insulin pump therapy or SGLT2 inhibitors AND symptoms of Diabetic Ketoacidosis. &amp;nbsp;Symptoms include but not limited to polyuria, thirst, nausea/vomiting, abdominal pain, weakness, mental status change, recent weight loss, and coma).&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value='Beta-Hydroxybutyrate (BOH); Blood, Venous; Conditional PRN']/activities[at0156]">    <items>      <item>        <key>Transform.Preselected</key>        <value>&lt;p&gt;Y&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value='Urinalysis; As needed']/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;To be released if blood glucose of greater than 18 mmol/L or greater than 14 mmol/L on self-management of insulin pump therapy or SGLT2 inhibitors AND symptoms of Diabetic Ketoacidosis. &amp;nbsp;Symptoms include but not limited to polyuria, thirst, nausea/vomiting, abdominal pain, weakness, mental status change, recent weight loss, and coma).&lt;/p&gt;&lt;p&gt;To be used only when serum beta-hydroxybutyrate is not available.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value='Urinalysis, POCT; Conditional PRN']/activities[at0001]">    <items>      <item>        <key>CKT.Content Details</key>        <value>&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;To be released if blood glucose of greater than 18 mmol/L or greater than 14 mmol/L on self-management of insulin pump therapy or SGLT2 inhibitors AND symptoms of Diabetic Ketoacidosis. &amp;nbsp;Symptoms include but not limited to polyuria, thirst, nausea/vomiting, abdominal pain, weakness, mental status change, recent weight loss, and coma).&lt;/p&gt;&lt;p&gt;To be used only when serum beta-hydroxybutyrate is not available.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>      </item>    </items>  </annotations>  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Ketone Testing for patients on Insulin or SGLT2 Inhibitors">    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items" />    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="991ba455-614e-4c92-b890-e8daffecdabb" concept_name="LAB Beta-Hydroxybutyrate (BOH) Order" max="1" path="/items" name="Beta-Hydroxybutyrate (BOH); Blood, Venous; Conditional PRN" />    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="384a2bd0-a6cd-4355-a421-a87822e31f2a" concept_name="LAB Urinalysis Order" max="1" path="/items" name="Urinalysis; As needed" />    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a5014e76-dbf6-4c5b-869d-84217c4769bc" concept_name="LAB Urinalysis POCT Order" max="1" path="/items" name="Urinalysis, POCT; Conditional PRN" />    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items" />  </definition>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>  </integrity_checks>  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>  </integrity_checks></template>